Nicholas C Popescu

Nicholas C Popescu

UNVERIFIED PROFILE

Are you Nicholas C Popescu?   Register this Author

Register author
Nicholas C Popescu

Nicholas C Popescu

Publications by authors named "Nicholas C Popescu"

Are you Nicholas C Popescu?   Register this Author

55Publications

846Reads

47Profile Views

Cooperative antiproliferative effect of coordinated ectopic expression of DLC1 tumor suppressor protein and silencing of MYC oncogene expression in liver cancer cells: Therapeutic implications.

Oncol Lett 2016 Aug 24;12(2):1591-1596. Epub 2016 Jun 24.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 2089-4262, USA; Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2016.4781DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4950702PMC
August 2016

Deleted in liver cancer-1 (DLC1): an emerging metastasis suppressor gene.

Mol Diagn Ther 2014 Jun;18(3):293-302

Laboratory of Experimental Carcinogenesis, National Cancer Institute, Building 37, Room 4140, 37 Convent Dr., MSC 4262, Bethesda, MD, 20892-4262, USA,

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40291-014-0086-3DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4032595PMC
June 2014

DLC1 suppresses NF-κB activity in prostate cancer cells due to its stabilizing effect on adherens junctions.

Springerplus 2014 14;3:27. Epub 2014 Jan 14.

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, 37 Convent Drive, MSC 4262, Bethesda, Maryland 20892 USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/2193-1801-3-27DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967735PMC
March 2014

Isolation of Mouse Embryo Fibroblasts.

Bio Protoc 2013 Sep;3(18)

Laboratory of Cellular Oncology, National Cancer Institute, NIH, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4928858PMC
http://dx.doi.org/10.21769/bioprotoc.908DOI Listing
September 2013

In vitro and in vivo effects of geranylgeranyltransferase I inhibitor P61A6 on non-small cell lung cancer cells.

BMC Cancer 2013 Apr 22;13:198. Epub 2013 Apr 22.

Molecular Cytogenetics Section, Lab. of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2407-13-198DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639152PMC
April 2013

Inactivation of the Dlc1 gene cooperates with downregulation of p15INK4b and p16Ink4a, leading to neoplastic transformation and poor prognosis in human cancer.

Cancer Res 2012 Nov 25;72(22):5900-11. Epub 2012 Sep 25.

Laboratories of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-12-2368DOI Listing
November 2012

Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).

Int J Oncol 2012 Aug 10;41(2):393-406. Epub 2012 May 10.

Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2012.1474DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3583004PMC
August 2012

DLC1 interaction with α-catenin stabilizes adherens junctions and enhances DLC1 antioncogenic activity.

Mol Cell Biol 2012 Jun 2;32(11):2145-59. Epub 2012 Apr 2.

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://mcb.asm.org/cgi/doi/10.1128/MCB.06580-11
Publisher Site
http://dx.doi.org/10.1128/MCB.06580-11DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372231PMC
June 2012

Preclinical evaluation of combined antineoplastic effect of DLC1 tumor suppressor protein and suberoylanilide hydroxamic acid on prostate cancer cells.

Biochem Biophys Res Commun 2012 Apr 7;420(2):325-30. Epub 2012 Mar 7.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S0006291X1200432
Publisher Site
http://dx.doi.org/10.1016/j.bbrc.2012.02.158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3322246PMC
April 2012

Restoration of senescence in breast and ovarian cancer cells following the transfer of the YAC carrying SEN6A gene located at 6q16.3.

Cancer Genomics Proteomics 2011 Sep-Oct;8(5):227-33

Temple University, School of Medicine, Philadelphia, PA 19140, U.S.A.

View Article

Download full-text PDF

Source
February 2012

DLC1 interaction with S100A10 mediates inhibition of in vitro cell invasion and tumorigenicity of lung cancer cells through a RhoGAP-independent mechanism.

Cancer Res 2011 Apr 3;71(8):2916-25. Epub 2011 Mar 3.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/cgi/doi/10.1158/0008-5472.
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-10-2158DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3078213PMC
April 2011

Synergistic antineoplastic effect of DLC1 tumor suppressor protein and histone deacetylase inhibitor, suberoylanilide hydroxamic acid (SAHA), on prostate and liver cancer cells: perspectives for therapeutics.

Int J Oncol 2010 Apr;36(4):999-1005

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo_00000580DOI Listing
April 2010

Role of SV40 integration site at chromosomal interval 1q21.1 in immortalized CRL2504 cells.

Cancer Res 2009 Oct 29;69(19):7819-25. Epub 2009 Sep 29.

Fels Institute for Cancer Research and Molecular Biology, Temple University School of Medicine, Philadelphia,PA 19140,USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-09-1003DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2913896PMC
October 2009

Acquired genetic and functional alterations associated with transforming growth factor beta type I resistance in Hep3B human hepatocellular carcinoma cell line.

J Cell Mol Med 2009 Sep 1;13(9B):3985-92. Epub 2009 May 1.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2009.00769.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516545PMC
September 2009

Recurrent and nonrandom DNA copy number and chromosome alterations in Myc transgenic mouse model for hepatocellular carcinogenesis: implications for human disease.

Cancer Genet Cytogenet 2009 May;191(1):17-26

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, 37 Convent Drive MSC 4262, Building 37, Room 4128B, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546080900043
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2008.12.014DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2693875PMC
May 2009

DLC-1:a Rho GTPase-activating protein and tumour suppressor.

J Cell Mol Med 2007 Sep-Oct;11(5):1185-207

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2007.00098.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4401278PMC
January 2008

Delayed kinetics of DNA double-strand break processing in normal and pathological aging.

Aging Cell 2008 Jan 19;7(1):89-100. Epub 2007 Dec 19.

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://doi.wiley.com/10.1111/j.1474-9726.2007.00354.x
Publisher Site
http://dx.doi.org/10.1111/j.1474-9726.2007.00354.xDOI Listing
January 2008

Morphological changes and nuclear translocation of DLC1 tumor suppressor protein precede apoptosis in human non-small cell lung carcinoma cells.

Exp Cell Res 2007 Nov 21;313(18):3868-80. Epub 2007 Aug 21.

Laboratory of Molecular Genetics, Toxicology and Molecular Biology Branch, National Institute for Occupational Safety and Health, CDC, Morgantown, WV 26505, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S001448270700389
Publisher Site
http://dx.doi.org/10.1016/j.yexcr.2007.08.009DOI Listing
November 2007

The interferon-alpha responsive gene TMEM7 suppresses cell proliferation and is downregulated in human hepatocellular carcinoma.

Cancer Genet Cytogenet 2007 Aug;177(1):6-15

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Building 37, Room 4128, 37 Convent Drive, MSC 4264, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546080700221
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2007.04.007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2034301PMC
August 2007

Inhibition of cell proliferation, induction of apoptosis, reactivation of DLC1, and modulation of other gene expression by dietary flavone in breast cancer cell lines.

Cancer Detect Prev 2007 6;31(2):110-8. Epub 2007 Apr 6.

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, 37 Convent Drive, MSC 4264, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.cdp.2007.02.005DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1950447PMC
July 2007

Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.

Proc Natl Acad Sci U S A 2007 May 15;104(21):9012-7. Epub 2007 May 15.

Laboratory of Cellular Oncology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.0703033104DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1868654PMC
May 2007

Expression profile of the tumor suppressor genes DLC-1 and DLC-2 in solid tumors.

Int J Oncol 2006 Nov;29(5):1127-32

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
November 2006

Effect of hepatitis C virus core protein on the molecular profiling of human B lymphocytes.

Mol Med 2006 Jan-Mar;12(1-3):47-53

Division of Hematology, Center for Biologics Evaluation and Research, Food and Drug Administration, Bethesda, MD 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2119/2006-00020.WuDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1514550PMC
September 2006

Aberrant methylation and deacetylation of deleted in liver cancer-1 gene in prostate cancer: potential clinical applications.

Clin Cancer Res 2006 Mar;12(5):1412-9

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4262, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-05-1906DOI Listing
March 2006

POTE paralogs are induced and differentially expressed in many cancers.

Cancer Res 2006 Jan;66(1):52-6

Laboratory of Molecular Biology, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, Maryland 20892-4264, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-3014DOI Listing
January 2006

GTF2IRD1 in craniofacial development of humans and mice.

Science 2005 Nov 3;310(5751):1184-7. Epub 2005 Nov 3.

Academic Unit of Medical Genetics, University of Manchester, St. Mary's Hospital, Manchester M13 9PL, UK.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.1116142DOI Listing
November 2005

Chromosomal aberrations in cell lines derived from thyroid tumors spontaneously developed in TRbetaPV/PV mice.

Cancer Genet Cytogenet 2005 Sep;161(2):104-9

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, 37 Convent Drive MSC 4262, Building 37/Room 4128C, Bethesda, MD 20892-4262, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S016546080500094
Publisher Site
http://dx.doi.org/10.1016/j.cancergencyto.2005.02.007DOI Listing
September 2005

The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Cancer Res 2005 Jul;65(14):6042-53

Department of Pathology, University of Florida Health Science Center, Shands Hospital, Jacksonville, Florida 32209-6511, USA.

View Article

Download full-text PDF

Source
http://cancerres.aacrjournals.org/lookup/doi/10.1158/0008-54
Publisher Site
http://dx.doi.org/10.1158/0008-5472.CAN-04-3043DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1360170PMC
July 2005

Aberrant gene expression in human non small cell lung carcinoma cells exposed to demethylating agent 5-aza-2'-deoxycytidine.

Neoplasia 2004 Jul-Aug;6(4):412-9

Laboratory of Cancer Genetics, Toxicology and Molecular Biology Branch, National Institute for Occupational Safety and Health, 1095 Willowdale Road, Morgantown, WV 26505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1593/neo.03490DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502114PMC
April 2005

DLC-1, a Rho GTPase-activating protein with tumor suppressor function, is essential for embryonic development.

FEBS Lett 2005 Feb 19;579(5):1191-6. Epub 2005 Jan 19.

Laboratory of Experimental Carcinogenesis, National Cancer Institute, National Institutes of Health, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.febslet.2004.12.090DOI Listing
February 2005

SMAD5 gene expression, rearrangements, copy number, and amplification at fragile site FRA5C in human hepatocellular carcinoma.

Neoplasia 2003 Sep-Oct;5(5):390-6

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, NIH, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1502609PMC
http://dx.doi.org/10.1016/s1476-5586(03)80041-6DOI Listing
July 2004

Thirteen-exon-motif signature for vertebrate nuclear and mitochondrial type IB topoisomerases.

Nucleic Acids Res 2004 19;32(7):2087-92. Epub 2004 Apr 19.

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, NIH, DHHS, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/nar/gkh525DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC407812PMC
May 2004

Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells.

Oncogene 2004 Feb;23(6):1308-13

1Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207246DOI Listing
February 2004

DLC-1 operates as a tumor suppressor gene in human non-small cell lung carcinomas.

Oncogene 2004 Feb;23(7):1405-11

Laboratory of Genetic Susceptibility, Toxicology and Molecular Biology Branch, Health Effects Laboratory Division, National Institute for Occupational Safety and Health, Morgantown, WV 26505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207291DOI Listing
February 2004

Senescing human cells and ageing mice accumulate DNA lesions with unrepairable double-strand breaks.

Nat Cell Biol 2004 Feb;6(2):168-70

Laboratory of Molecular Pharmacology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/ncb1095DOI Listing
February 2004

Fragile sites and cancer genes on the short arm of chromosome 8.

Lancet Oncol 2004 Feb;5(2):77; discussion 77

Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(04)01377-4DOI Listing
February 2004

High-penetrance mouse model of acute promyelocytic leukemia with very low levels of PML-RARalpha expression.

Blood 2003 Sep 15;102(5):1857-65. Epub 2003 May 15.

Washington University, Division of Oncology, 660 S Euclid Ave, Campus Box 8007, St Louis, MO 63110-1093, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1182/blood-2002-12-3779DOI Listing
September 2003

DNA variants of DLC-1, a candidate tumor suppressor gene in human hepatocellular carcinoma.

Int J Oncol 2003 Jul;23(1):133-7

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute/NIH, 37 Convent Drive, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
July 2003

Genetic alterations in cancer as a result of breakage at fragile sites.

Cancer Lett 2003 Mar;192(1):1-17

Molecular Cytogenetics Section, Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20814-4958, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0304-3835(02)00596-7DOI Listing
March 2003

Amplification and overexpression of the EMS 1 oncogene, a possible prognostic marker, in human hepatocellular carcinoma.

J Mol Diagn 2003 Feb;5(1):48-53

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland 20892-4258, USA.

View Article

Download full-text PDF

Source
http://linkinghub.elsevier.com/retrieve/pii/S152515781060451
Publisher Site
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1907373PMC
http://dx.doi.org/10.1016/S1525-1578(10)60451-5DOI Listing
February 2003

DLC-1 gene inhibits human breast cancer cell growth and in vivo tumorigenicity.

Oncogene 2003 Jan;22(3):445-50

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206064DOI Listing
January 2003

Identification and characterization of a gene encoding a putative mouse Rho GTPase activating protein gene 8, Arhgap8.

Gene 2003 Jan;303:55-61

Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-1119(02)01143-5DOI Listing
January 2003

Promoter hypermethylation of DLC-1, a candidate tumor suppressor gene, in several common human cancers.

Cancer Genet Cytogenet 2003 Jan;140(2):113-7

Health Effects Laboratory Division, Toxicology and Molecular Biology Branch, National Institute for Occupational Safely and Health, Morgantown, WV 26505, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0165-4608(02)00674-xDOI Listing
January 2003

POTE, a highly homologous gene family located on numerous chromosomes and expressed in prostate, ovary, testis, placenta, and prostate cancer.

Proc Natl Acad Sci U S A 2002 Dec 10;99(26):16975-80. Epub 2002 Dec 10.

Laboratories of Molecular Biology and Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4264, USA.

View Article

Download full-text PDF

Source
http://www.pnas.org/cgi/doi/10.1073/pnas.262655399
Publisher Site
http://dx.doi.org/10.1073/pnas.262655399DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC139254PMC
December 2002

Chromosome and gene alterations in breast cancer as markers for diagnosis and prognosis as well as pathogenetic targets for therapy.

Am J Med Genet 2002 Oct;115(3):142-9

Molecular Cytogenetics Section, Laboratory of Experimental Carcinogenesis, Center for Cancer Research, National Cancer Institute, Building 37, Room 3C05, 37 Convent Drive MSC 4258, Bethesda, MD 20892-4258, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/ajmg.10696DOI Listing
October 2002

Comprehensive genetic analysis of cancer cells.

J Cell Mol Med 2000 Jul-Sep;4(3):151-163

National Cancer Institute, 37/3C05, 37 Convent Drive MSC 4255, Bethesda, Md 20892-4255, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/j.1582-4934.2000.tb00113.xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6741355PMC
August 2002

The fragile histidine triad/common chromosome fragile site 3B locus and repair-deficient cancers.

Cancer Res 2002 Jul;62(14):4054-60

Department of Radiation Oncology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, Pennsylvania 19107, USA.

View Article

Download full-text PDF

Source
July 2002

Gene structure, tissue expression, and linkage mapping of the mouse DLC-1 gene (Arhgap7).

Gene 2002 Apr;288(1-2):119-27

Laboratory of Experimental Carcinogenesis, Building 37, Room 3C28, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0378-1119(02)00462-6DOI Listing
April 2002